GSK asks US court to block Teva's launch of generic AIDS drug
12 March 2010
Nancy Faigen
GlaxoSmithkline has filed a motion in a US federal court for a preliminary injunction to bar
Teva Pharmaceutical Industries from an apparent planned May launch of a generic version of GSK's HIV/AIDS drug Combivir (zidovudine and lamivudine).
In the March 5th motion for preliminary injunction,...
Please Login to read the full article.
12 March 2010
Nancy Faigen
In the March 5th motion for preliminary injunction,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Watson beatsTeva on appeals overgeneric Seasonique: sued by Novartis over Exelon
- Mylan loses bid to have US Teva patent infringement suit on Copaxone tossed out
- US Capitol Capsule: Supreme Court to weigh generic drug liability, patent burden-of-proof standards
- Lupin gets final US FDA approval for generic LoSeasonique
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
